No Data
No Data
HeartBeam Prices $10.0M Underwritten Public Offering Of 5,882,353 Shares At $1.70/Share
HeartBeam Announces Pricing of $10.0 Million Underwritten Public Offering of Common Stock
US Penny Stocks Spotlight: HeartBeam And Two More Standout Picks
Heartbeam Has Submitted A 510(K) Application To The U.S. Food And Drug Administration For The Company's 12-Lead Electrocardiogram Synthesis Software Designed For The Assessment Of Rhythms And Arrhythmias
Express News | Heartbeam : Submitted a 510(K) Application to U.S. FDA for Co's 12-Lead Electrocardiogram (Ecg) Synthesis Software
HeartBeam Achieves Major Milestone With FDA Submission for Its Groundbreaking 12-Lead ECG Synthesis Software